AppleOne Medical Group (AMG), the healthcare arm of the AppleOne Group of companies, has set out to upgrade the laboratory services and the medical arts of VisayasMed Hospital in Cebu City by formally signing a partnership with Singapore Diagnostics (SGD) on Wednesday, April 19.
(From left to right) Singapore Diagnostics Acting CFO Alexander Apollo S. Arellano, AppleOne CFO Leif Bajarias, VisayasMed Hospital Cebu CEO Leopoldo Amistoso Jr, Singapore Diagnostics President and CE Ritche Joseph Manuel D. Evidente, VisayasMed Hospital Cebu Medical Director Dr. Eribal Maritzie, AppleOne Medical Group Vice Chairman and Treasurer Venus H. Manigsaca, AppleOne SVP for Banking Relations and Special Projects Barbara P. Cabo, Singapore Diagnostics COO Norely B. Gil, AppleOne Medical Group Member of the Board Lilibeth H. Cunanan, AppleOne Medical Group EVP Engr. Oscar Tuason
VisayasMed Hospital, formerly known as Visayas Community Medical Center, is a private tertiary hospital with close to 70 years of healthcare experience in providing quality medical services to patients. It comprises five main departments namely family medicine, pediatrics, internal medicine, surgery, obstetrics and gynecology, and other departments that offer services from medical professionals in dermatology, psychiatry, ophthalmology, and anesthesiology.
SGD, on the other hand, is the Philippine flagship company of Singapore-based healthcare group, Pathology Asia. It is the first laboratory in the Philippines accredited by the College of American Pathologists (CAP), which makes it at par with the worlds’ best laboratories and has been awarded as Healthcare Asia’s Diagnostics Provider of the year and STATISTA’s Philippines’ Growth Champion of the year.
From its establishment in late 2013, Singapore Diagnostics (SGD) has grown to be among the largest laboratories in the Philippines. Processing laboratory tests for over 600 hospitals, clinic labs and healthcare institutions in the Philippines, SGD serves up to 50,000 patients every month, and conducts over 3.6 million laboratory examinations per year.
Through its partnership with SGD, VisayasMed Hospital will be able to carry out its main goal of providing a holistic patient experience by offering a more convenient and personalized approach to healthcare as SGD is known for its global expertise and technology.
SGD will fully operate VisayasMed’s laboratory, both inpatient and outpatient, through their well-trained medical technologists and laboratory specialists. Additionally, SGD also aims to become a well-equipped training venue for the best scientists of Cebu for continuous improvement.
“Reeling from the pandemic where we saw the paramount need for quality health and laboratory services, we at AppleOne, are honored to work together with SGD. With our goal of enriching the lives of Filipinos, we will be working together in expanding SGD’s services to other AppleOne Medical Group Hospitals across the VisMin region. Our patients can be more assured of the highest standards of quality competence and safety when it comes to their laboratory tests.” said Leif Bajarias, CFO AppleOne
